Issue 2/2012
Content (8 Articles)
Risk Evaluation and Mitigation Strategies (REMS)
Susan C. Nicholson, Janet Peterson, Behin Yektashenas
Methods for Assessing the Preventability of Adverse Drug Events
Katja Marja Hakkarainen, Karolina Andersson Sundell, Max Petzold, Staffan Hägg
Effects of Proton Pump Inhibitors on Platelet Function in Patients Receiving Clopidogrel
Chun Shing Kwok, Yoon Kong Loke
Selected National Pharmacovigilance Websites
Charlotte I.S. Barker, John C.C. Talbot, Jeffrey K. Aronson
Trends in Hepatic Injury Associated with Unintentional Overdose of Paracetamol (Acetaminophen) in Products with and without Opioid
G. Randall Bond, Mona Ho, Randall W. Woodward
Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinson’s Disease and Hyperprolactinaemia
Gianluca Trifirò, M. Mostafa Mokhles, Jeanne P. Dieleman, Eva M. van Soest, Katia Verhamme, Giampiero Mazzaglia, Ron Herings, Cynthia de Luise, Douglas Ross, Guy Brusselle, Annamaria Colao, Wilhelm Haverkamp, Rene chade, Guy van Camp, Renzo Zanettini, Miriam C. Sturkenboom